Incyte Corp. (INCY)
100.05
-8.98
(-8.24%)
USD |
NASDAQ |
Feb 10, 16:00
99.34
-0.71
(-0.71%)
After-Hours: 20:00
Incyte Profit Margin (Quarterly) : 19.86% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 34.40% |
| Centene Corp. | -2.21% |
| Pfizer Inc. | -9.34% |
| Bio-Techne Corp. | 12.84% |
| Vertex Pharmaceuticals, Inc. | 34.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 30.48% |
| Return on Assets | 21.20% |
| Return on Invested Capital | 30.17% |
| Gross Profit Margin (Quarterly) | 92.32% |
| Operating Margin (Quarterly) | 25.48% |
| Return on Net Operating Assets | 61.18% |